Stock CMOTEC B SCANDINAVIAN CHEMOTECH AB
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Scandinavian ChemoTech AB

Equities

CMOTEC B

SE0009242654

Delayed Nasdaq Stockholm
Other stock markets
 10:19:07 2024-05-13 EDT 		5-day change 1st Jan Change
2.51 SEK +9.61% Intraday chart for Scandinavian ChemoTech AB +11.06% -7.04%
05-07 Scandinavian ChemoTech AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-22 Scandinavian Chemotech AB Obtains Approval of the Third and Last Patent Application in India CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Scandinavian ChemoTech - Starting the year on the right foot
AQ
Scandinavian ChemoTech announces departure of QM & RA Director Eva Ståhl Wernersson
AQ
ChemoTech obtain approval of the third and last patent application in India
AQ
ChemoTech attains progress by obtaining patent protection for two essential patents in India
AQ
Scandinavian ChemoTech's Animal Care embarks on an exciting journey along with Equitom to forge a cutting-edge Centre of Excellence
AQ
ChemoTech secures order from the largest European state-of-the-art equine (horse) clinic
AQ
IQwave™ Receives Certification for Tumour Treatment in Singapore
AQ
Scandinavian ChemoTech - Weathering the storm
AQ
ChemoTech signs new agreement with a private hospital & medical college
AQ
ChemoTech adapts its strategy and short-term targets for Human Care
AQ
Scandinavian ChemoTech AB (publ) Year-End Report January - December 2023 - Executive Summary
AQ
New order received for the Innovative TSE Cancer Treatment Technology
AQ
Invitation to Presentation on the recent Ethics Committee Approval and Clinical Strategy
AQ
Ground-breaking milestone in Head & Neck cancer treatment achieved
AQ
Scandinavian ChemoTech Celebrates Year-End Success with insightful TSE Case Reports
AQ
Scandinavian ChemoTech's Animal Care division receives an order from a leading veterinary hospital in south Florida, USA
AQ
Scandinavian ChemoTech push forward previously communicated target of 15 commercial installations in India to Q1-2024
AQ
Scandinavian ChemoTech thanks for the cooperation with its IR consultant who leaves the management team
AQ
Scandinavian ChemoTech updates on its most important milestone
AQ
Scandinavian ChemoTech - Financing required
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CMOTEC B Stock
  4. News Scandinavian ChemoTech AB
  5. Press Releases
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW